Advanced search
Publication Cover
Biomarkers Volume 25, 2020 - Issue 2
Submit an article Journal homepage
120
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

A specific autoantibody against a novel tumour-association antigen derived from human DNA-topoiomerase I is a potential biomarker for early diagnosis and favourable prognosis in patients with colorectal carcinoma

Feng ZhaoState Key Laboratory of Biotherapy and Cancer, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, PR China; View further author information
,
Mei CaoCore Laboratory, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospitals, Chengdu, PR China; View further author information
,
Xiao-Hui JiangKey Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Chengdu, PR China; Correspondence[email protected]
View further author information
,
Ke XieDepartment of Oncology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospitals, Chengdu, PR China; View further author information
,
Shang-Rong YeChengdu Cancer Bioengineering Research Institute, Chengdu, PR ChinaView further author information
&
Shang-Mian YieChengdu Cancer Bioengineering Research Institute, Chengdu, PR ChinaCorrespondence[email protected]
View further author information
Pages 149-156 | Received 19 Dec 2018, Accepted 05 Jan 2020, Published online: 27 Jan 2020

References

  • Carter, P., 2001. Improving the efficacy of antibody-based cancer therapies. Nature reviews cancer, 1 (2), 118–129.
  • Chen, H., et al., 2014. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer. Cancer letters, 346 (2), 178–187.
  • Chen, W., et al., 2016. Cancer statistics in China, 2015. CA: a cancer journal for clinicians, 66 (2), 115–132.
  • Duffy, M.J., et al., 2014. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. International journal of cancer, 134 (11), 2513–2522.
  • Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti A. editors, 2010. AJCC cancer staging manual. 7th ed. New York, NY: Springer.
  • Finn, O.J., 2005. Immune response as a biomarker for cancer detection and a lot more. New England journal of medicine, 353 (12), 1288–1290.
  • Heo, C.K., Bahk, Y.Y., and Cho, E.W., 2012. Tumor-associated autoantibodies as diagnostic and prognostic biomarkers. BMB reports , 45 (12), 677–685.
  • Jemal, A., et al., 2011. Global cancer statistics. CA: a cancer journal for clinicians, 61, 69–90.
  • Kobold, S., et al., 2010. Prognostic and diagnostic value of spontaneous tumor-related antibodies. Clinical and developmental immunology, 2010, 1–8.
  • Reuschenbach, M., von Knebel Doeberitz, M., and Wentzensen, N., 2009. A systematic review of humoral immune responses against tumor antigens. Cancer immunology, immunotherapy, 58 (10), 1535–1544.
  • Ro, T.H., Mathew, M.A., and Misra, S., 2015. Value of screening endoscopy in evaluation of esophageal, gastric and colon cancers. World journal of gastroenterology, 21 (33), 9693–9706.
  • Sahin, U., et al., 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proceedings of the national academy of sciences, 92 (25), 11810–11813.
  • Suppiah, A. and Greenman, J., 2013. Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer. World journal of gastroenterology, 19 (29), 4651–4670.
  • Tan, E.M., 2001. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. Journal of clinical investigation, 108 (10), 1411–1415.
  • Wagner, P.D., Verma, M., and Srivastava, S., 2004. Challenges for biomarkers in cancer detection. Annals of the New York academy of sciences, 1022 (1), 9–16.
  • Wu, W.B., et al., 2018. An autoantibody against human DNA-topoiomerase I is a novel biomarker for non-small cell lung cancer. The annals of thoracic surgery, 105 (6), 1664–1670.
  • Yie, S.M., et al., 2016. A protein fragment derived from DNA-topoisomerase I as a novel tumour-associated antigen for the detection of early stage carcinoma. British journal of cancer, 115 (12), 1555–1564.
  • Zaenker, P. and Ziman, M.R., 2013. Serologic autoantibodies as diagnostic cancer biomarkers–a review. Cancer epidemiology biomarkers & prevention, 22 (12), 2161–2181.
  • Zaenker, P., Gray, E.S., and Ziman, M.R., 2016. Autoantibody production in cancer-the humoral immune response toward autologous antigens in cancer patients. Autoimmunity reviews, 15 (5), 477–483.
  • Zhang, J.B., et al., 2018. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma. Clinics and research in hepatology and gastroenterology, 42 (3), 276–284.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.